The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index) (Q67983004)
Jump to navigation
Jump to search
scientific article published on 01 October 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index) |
scientific article published on 01 October 1992 |
Statements
The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index) (English)
Tanneberger S
G. Lelli
A. Martoni
E. Piana
1 October 1992